NLRP3 and gout: Furthermore, cardamonin [52] and mastoparan M [53] could ameliorate joint inflammation by suppressing NLRP3 inflammasome activation in iron-overload-induced arthritis and MSU-crystal-induced gouty arthritis, respectively.